Skip to main content
. 2023 May 15;13(5):836. doi: 10.3390/jpm13050836

Table 3.

Disease severity of patients with septic shock with regard to sex.

Characteristics All
(n = 373)
Male
(n = 237)
Female
(n = 136)
p-Value
Sepsis Severity
Sequential Organ Failure Assessment (SOFA) 9 ± 3.9 9.2 ± 3.8 8.7 ± 4 0.1264
Days in septic shock 2 (1, 3) 2 (1, 3) 2 (1, 4) 0.1425
ICU length of stay 24 ± 19 23 ± 16 25 ± 24 0.9666
Hospital length of stay 42 ± 31 43 ± 31 40 ± 31 0.4649
Inflammatory Values
Leukocytes [1000/µL] 13.9 ± 5.5 13.8 ± 5.7 14.2 ± 5.2 0.3576
C-reactive protein [mg/L] (n = 219) 156 ± 79 160 ± 79 147 ± 78 0.2204
Procalcitonin [ng/dL] (n = 352) 1.8 (0.7, 5.9) 2.2 (0.9, 6.1) 1.4 (0.5, 5.4) 0.0804
Respiratory Values
SOFA respiratory subscore 2.2 ± 0.7 2.3 ± 0.8 2.1 ± 0.7 0.1089
Ventilated days 13 ± 9 13 ± 9 13 ± 9 0.9130
Patients with mechanical ventilation [%] 97 97 96 0.8788
Ventilation days/observation days [%] 74 ± 29 75 ± 29 73 ± 30 0.8123
Coagulation
SOFA coagulation subscore 0.2 (0, 0.9) 0.2 (0, 1) 0.3 (0, 0.9) 0.9773
Thrombocytes [1000/µL] 251 ± 142 257 ± 154 240 ± 118 0.7232
Liver Values
SOFA hepatic subscore 0.1 (0, 1) 0.1 (0, 0.9) 0.1 (0, 1) 0.6701
Bilirubin [mg/dL] 0.8 (0.5, 1.6) 0.8 (0.5, 1.6) 0.7 (0.4, 1.7) 0.1118
AST (GOT) [IU/L] (n = 291) 69 (40, 140) 71 (41, 160) 67 (38, 121) 0.6234
ALT (GPT) [IU/L] (n = 362) 44 (22, 101) 49 (25, 98) 37 (19, 106) 0.0964
Cardiovascular Values
SOFA cardiovascular subscore 2.1 ± 1 2.1 ± 1 2.1 ± 1 0.7594
Vasopressor days 8 ± 6 8 ± 6 9 ± 7 0.7382
Patients with vasopressor treatment [%] 100 100 100 1.0
Vasopressor days/observation days [%] 52 ± 30 51 ± 30 53 ± 30 0.5564
Central Nervous System
SOFA central nervous system 2.3 ± 1 2.3 ± 1 2.3 ± 1 0.8255
Glasgow Coma Scale (GCS) 9 ± 3 9 ± 3 9 ± 3 0.9277
Renal Values
SOFA renal subscore 0.6 (0.1, 2) 0.8 (0.2, 2.3) 0.3 (0, 1.3) 0.0021
Creatinine [mg/dL] 1.4 ± 1 1.6 ± 1 1.1 ± 0.7 <0.001
Urine output [mL/d] 2661 ± 1540 2661 ± 1549 2661 ± 1531 0.9924
Urine output [mL/kg/d] 1.4 ± 0.8 1.3 ± 0.8 1.5 ± 0.9 0.0326
Dialysed days 0 (0, 4) 0 (0, 4) 0 (0, 3) 0.1682
Patients with renal replacement therapy [%] 39 43 32 0.0503
Dialysis days/observation days [%] 0 (0, 28) 0 (0, 33) 0 (0, 18) 0.1027